166 related articles for article (PubMed ID: 11736717)
1. Clinical and endoscopic characteristics of non-Helicobacter pylori, non-NSAID duodenal ulcers: a long-term prospective study.
Xia HH; Wong BC; Wong KW; Wong SY; Wong WM; Lai KC; Hu WH; Chan CK; Lam SK
Aliment Pharmacol Ther; 2001 Dec; 15(12):1875-82. PubMed ID: 11736717
[TBL] [Abstract][Full Text] [Related]
2. Demographic and endoscopic characteristics of patients with Helicobacter pylori positive and negative peptic ulcer disease.
Xia HH; Phung N; Kalantar JS; Talley NJ
Med J Aust; 2000 Nov; 173(10):515-9. PubMed ID: 11194733
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori and bleeding duodenal ulcer: prevalence of the infection and role of non-steroidal anti-inflammatory drugs.
Gisbert JP; Gonzalez L; de Pedro A; Valbuena M; Prieto B; Llorca I; Briz R; Khorrami S; Garcia-Gravalos R; Pajares JM
Scand J Gastroenterol; 2001 Jul; 36(7):717-24. PubMed ID: 11444470
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of non-Helicobacter pylori duodenal ulcer in Karachi, Pakistan.
Yakoob J; Jafri W; Jafri N; Islam M; Abid S; Hamid S; AliShah H; Shaikh H
World J Gastroenterol; 2005 Jun; 11(23):3562-5. PubMed ID: 15962375
[TBL] [Abstract][Full Text] [Related]
5. Ulcer site and complications: relation to Helicobacter pylori infection and NSAID use.
al-Assi MT; Genta RM; Karttunen TJ; Graham DY
Endoscopy; 1996 Feb; 28(2):229-33. PubMed ID: 8739738
[TBL] [Abstract][Full Text] [Related]
6. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.
Xia B; Xia HH; Ma CW; Wong KW; Fung FM; Hui CK; Chan CK; Chan AO; Lai KC; Yuen MF; Wong BC
Aliment Pharmacol Ther; 2005 Aug; 22(3):243-9. PubMed ID: 16091062
[TBL] [Abstract][Full Text] [Related]
7. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy.
Bianchi Porro G; Parente F; Imbesi V; Montrone F; Caruso I
Gut; 1996 Jul; 39(1):22-6. PubMed ID: 8881802
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Helicobacter pylori infection in duodenal ulcer and gastro-duodenal ulcer diseases in Taiwan.
Chen TS; Luo JC; Chang FY
J Gastroenterol Hepatol; 2010 May; 25(5):919-22. PubMed ID: 20074147
[TBL] [Abstract][Full Text] [Related]
9. The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe.
Arroyo MT; Forne M; de Argila CM; Feu F; Arenas J; de la Vega J; Garrigues V; Mora F; Castro M; Bujanda L; Cosme A; Castiella A; Gisbert JP; Hervas A; Lanas A
Helicobacter; 2004 Jun; 9(3):249-54. PubMed ID: 15165261
[TBL] [Abstract][Full Text] [Related]
10. Role of Helicobacter pylori infection and nonsteroidal anti-inflammatory drug use in bleeding peptic ulcers in Japan.
Ootani H; Iwakiri R; Shimoda R; Nakahara S; Amemori S; Fujise T; Kikkawa A; Tsunada S; Sakata H; Fujimoto K
J Gastroenterol; 2006 Jan; 41(1):41-6. PubMed ID: 16501856
[TBL] [Abstract][Full Text] [Related]
11. H. pylori-negative duodenal ulcer prevalence and causes in 774 patients.
Gisbert JP; Blanco M; Mateos JM; Fernández-Salazar L; Fernández-Bermejo M; Cantero J; Pajares JM
Dig Dis Sci; 1999 Nov; 44(11):2295-302. PubMed ID: 10573377
[TBL] [Abstract][Full Text] [Related]
12. Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers.
Chan FK; Sung JJ; Chung SC; To KF; Yung MY; Leung VK; Lee YT; Chan CS; Li EK; Woo J
Lancet; 1997 Oct; 350(9083):975-9. PubMed ID: 9329511
[TBL] [Abstract][Full Text] [Related]
13. Endoscopic characteristics and Helicobacter pylori infection in NSAID-associated gastric ulcer.
Kamada T; Hata J; Kusunoki H; Sugiu K; Tanimoto T; Mihara M; Hamada H; Kido S; Dongmei Q; Haruma K
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):98-102. PubMed ID: 16706819
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori, non-steroidal anti-inflammatory drugs and smoking in risk pattern of gastroduodenal ulcers.
Konturek SJ; Bielański W; Płonka M; Pawlik T; Pepera J; Konturek PC; Czarnecki J; Penar A; Jedrychowski W
Scand J Gastroenterol; 2003 Sep; 38(9):923-30. PubMed ID: 14531527
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori infection delays ulcer healing in patients operated on for perforated duodenal ulcer.
Kumar D; Sinha AN
Indian J Gastroenterol; 2002; 21(1):19-22. PubMed ID: 11871831
[TBL] [Abstract][Full Text] [Related]
16. Non-Helicobacter pylori related duodenal ulcer disease in children.
Elitsur Y; Lawrence Z
Helicobacter; 2001 Sep; 6(3):239-43. PubMed ID: 11683927
[TBL] [Abstract][Full Text] [Related]
17. Prevention of ulcer recurrence after eradication of Helicobacter pylori: a prospective long-term follow-up study.
Van der Hulst RW; Rauws EA; Köycü B; Keller JJ; Bruno MJ; Tijssen JG; Tytgat GN
Gastroenterology; 1997 Oct; 113(4):1082-6. PubMed ID: 9322501
[TBL] [Abstract][Full Text] [Related]
18. Is the new potent acid-inhibitory drug vonoprazan effective for healing idiopathic peptic ulcers? A multicenter observational study in Akita Prefecture, Japan.
Sugawara K; Koizumi S; Horikawa Y; Mimori N; Tsuji T; Ishii H; Fujimori S; Onochi K; Watanabe H; Iijima K
J Gastroenterol; 2019 Nov; 54(11):963-971. PubMed ID: 31037448
[TBL] [Abstract][Full Text] [Related]
19. The relative contribution of NSAIDs and Helicobacter pylori to the aetiology of endoscopically-diagnosed peptic ulcer disease: observations from a tertiary referral hospital in the UK between 2005 and 2010.
Musumba C; Jorgensen A; Sutton L; Van Eker D; Moorcroft J; Hopkins M; Pritchard DM; Pirmohamed M
Aliment Pharmacol Ther; 2012 Jul; 36(1):48-56. PubMed ID: 22554233
[TBL] [Abstract][Full Text] [Related]
20. Interaction of Helicobacter pylori infection and nonsteroidal anti-inflammatory drugs in gastric and duodenal ulcers.
Venerito M; Malfertheiner P
Helicobacter; 2010 Aug; 15(4):239-50. PubMed ID: 20633184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
